One study further showed that EZH2 inhibition resulted in reduced tumor size in mice with BAP1-inactivated mesotheliomas compared to wild-type mesotheliomas, providing evidence for the potential role of BAP1 in mediating tumor sensitivity to EZH2 inhibition [31]. Here, BAP1 is linked to neoplasm.